ACI
USNA icon

AMP Capital Investors’s Usana Health Sciences USNA Stock Holding History

AMP Capital Investors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,026
Closed -$295K – 1251
2021
Q1 		$295K Hold
3,026
– – ﹤0.01% 1101
2020
Q4 		$233K Sell
3,026
-2,438
-45% -$189K ﹤0.01% 1162
2020
Q3 		$396K Buy
5,464
+2,438
+81% +$196K ﹤0.01% 978
2020
Q2 		$217K Buy
+3,026
New +$237K ﹤0.01% 1105
2019
Q4 		– Sell
-3,600
Closed -$249K – 1250
2019
Q3 		$249K Sell
3,600
-2,160
-38% -$145K ﹤0.01% 1103
2019
Q2 		$442K Buy
+5,760
New +$457K ﹤0.01% 1012
2019
Q1 		– Sell
-2,160
Closed -$248K – 1203
2018
Q4 		$248K Hold
2,160
– – ﹤0.01% 1069
2018
Q3 		$262K Sell
2,160
-600
-22% -$74.5K ﹤0.01% 1100
2018
Q2 		$318K Sell
2,760
-4,300
-61% -$470K ﹤0.01% 1060
2018
Q1 		$602K Sell
7,060
-5,010
-42% -$388K ﹤0.01% 955
2017
Q4 		$894K Hold
12,070
– – ﹤0.01% 929
2017
Q3 		$696K Buy
12,070
+712
+6% +$42.1K ﹤0.01% 953
2017
Q2 		$729K Buy
11,358
+588
+5% +$36.2K ﹤0.01% 915
2017
Q1 		$628K Hold
10,770
– – ﹤0.01% 936
2016
Q4 		$669K Sell
10,770
-630
-6% -$41K ﹤0.01% 943
2016
Q3 		$776K Buy
11,400
+4,482
+65% +$296K ﹤0.01% 916
2016
Q2 		$376K Hold
6,918
– – ﹤0.01% 1004
2016
Q1 		$413K Buy
6,918
+3,600
+108% +$212K ﹤0.01% 986
2015
Q4 		$214K Buy
+3,318
New +$215K ﹤0.01% 1138
2015
Q2 		– Sell
-13,014
Closed -$732K – 1209
2015
Q1 		$732K Hold
13,014
– – ﹤0.01% 953
2014
Q4 		$673K Sell
13,014
-11,916
-48% -$585K ﹤0.01% 954
2014
Q3 		$910K Hold
24,930
– – 0.01% 911
2014
Q2 		$970K Hold
24,930
– – 0.01% 908
2014
Q1 		$923K Sell
24,930
-16,870
-40% -$589K 0.01% 892
2013
Q4 		$1.63M Sell
41,800
-13,260
-24% -$507K 0.01% 771
2013
Q3 		$2.4M Sell
55,060
-16,200
-23% -$650K 0.02% 664
2013
Q2 		$2.57M Buy
+71,260
New +$2.17M 0.02% 651

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AMP Capital Investors's USNA Position: Q2 2021 in Review

AMP Capital Investors sold out of Usana Health Sciences (USNA) in Q2 2021, closing a stake of 3,026 shares — an estimated $295K sold.

AMP Capital Investors first reported a position in USNA in Q2 2013 and held it in 27 quarters. The position peaked at $2.57M in Q2 2013. 188 funds tracked by Wall St. Rank hold USNA as of Q2 2021.

  • AMP Capital Investors reported no remaining Usana Health Sciences position as of Q2 2021 after selling out during the quarter.
  • AMP Capital Investors sold 3,026 Usana Health Sciences shares in Q2 2021, an estimated $295K.
  • AMP Capital Investors first reported a position in Usana Health Sciences in Q2 2013 and held it in 27 quarters.
  • AMP Capital Investors's Usana Health Sciences position peaked at $2.57M in Q2 2013.
  • 188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2021.

Based on AMP Capital Investors's 13F filing for Q2 2021, filed 16 Aug 2021.